Endo Pharmaceuticals to Present at J.P. Morgan 30th Annual Healthcare Conference
CHADDS FORD, Pa., Dec. 27, 2011 /PRNewswire/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that David Holveck, president and CEO will present a corporate overview at the J.P. Morgan 30th Annual Healthcare Conference on Monday, January 9, 2012 at 4:30 p.m. ET. The conference will be held at the Westin St. Francis in San Francisco, Calif.
A live webcast and audio archive of the presentation will be available on the company's website at http://www.endo.com/. Click on Investor Relations, and then the link to the Event and Presentation. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast.
Endo Pharmaceuticals is a U.S.-based, specialty healthcare solutions company with a diversified business model, operating in three key business segments - branded pharmaceuticals, generics and devices and services. We deliver an innovative suite of complementary products and services to meet the needs of patients in areas such as pain management, pelvic health, urology, endocrinology and oncology. For more information about Endo Pharmaceuticals Inc., and its wholly owned subsidiaries American Medical Systems and Qualitest Pharmaceuticals, as well as its affiliate, HealthTronics, Inc., please visit http://www.endo.com/.
SOURCE Endo Pharmaceuticals